Trials / Completed
CompletedNCT00768222
Coated VICRYL* Plus Suture Compared to Chinese Silk in Scheduled Breast Cancer Surgery
Pilot Evaluation of Cosmetic Outcome and Surgical Site Infection Rates of Coated VICRYL* Plus Antibacterial (Polyglactin 910) Suture Compared to Chinese Silk in Scheduled Breast Cancer Surgery
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 101 (actual)
- Sponsor
- Ethicon, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a 90-day study to evaluate cosmetic outcome and Surgical Site Infection in approximately 100 patients from 6 centers in China undergoing scheduled modified radical mastectomy for breast cancer.
Detailed description
Patients will be evaluated post-procedure on Days 3, 5, 7, 12, 30 and 90 for cosmetic outcome and surgical site infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | silk suture | skin closure |
| DEVICE | VICRYL* Plus suture | skin closure |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2009-03-01
- Completion
- 2009-05-01
- First posted
- 2008-10-08
- Last updated
- 2011-08-31
- Results posted
- 2011-08-25
Locations
6 sites across 1 country: China
Source: ClinicalTrials.gov record NCT00768222. Inclusion in this directory is not an endorsement.